Phase I study of GSK461364, a specific and competitive Polo-like Kinase 1 (PLK1) inhibitor in patients with advanced solid malignancies.

D. Olmos, D. Barker, A. Sharma, A.T. Brunetto, T.A. Yap, A. Taegtmeyer, A.J. Allred, D.A. Smith, S.A. Murray, T.A. Lampkin, M.M. Dar, Richard Wilson, J.S. De Bono, S.P. Blagden

Research output: Contribution to journalArticlepeer-review

115 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I study of GSK461364, a specific and competitive Polo-like Kinase 1 (PLK1) inhibitor in patients with advanced solid malignancies.'. Together they form a unique fingerprint.

Medicine & Life Sciences